A photo of Vincent Mukkada.

Vincent A. Mukkada, MD

  • Medical Director, Lumen Inpatient Unit
  • Interim Medical Director, Division of Gastroenterology, Hepatology, and Nutrition
  • Medical Director, A4S
  • Professor, UC Department of Pediatrics



I specialize in patient care and research related to pediatric gastroenterology — specifically, eosinophilic gastrointestinal (GI) disease and pediatric feeding disorders. The research I pursue is primarily influenced by the health issues that I see every day in the patients who have eosinophilic GI disease and pediatric feeding disorders. I have also become the medical director of our inpatient gastroenterology floor, where we work to continuously improve the quality of care we provide to our patients.

My colleagues and I are working to improve clinical care and monitoring of pediatric patients with eosinophilic disease. We want to better understand the causes and risk factors associated with developing complications in eosinophilic esophagitis. In addition, we are looking to improve the characterization and treatment of feeding problems found in patients with food allergic conditions.

A pediatric feeding disorder is impaired oral intake that is not age-appropriate and can be associated with medical, nutritional, feeding skill and/or psychosocial dysfunction. Continued research into the pathogenesis and best treatment approaches is essential to help children with these disorders.

I was inspired to become a healthcare provider due to my family’s involvement in the healthcare field. My mother is a physician and my father is an academic scientist with a Ph.D. in microbiology. Healthcare and biology surrounded me as I was growing up. While I first resisted following this path, I soon realized that this was the right fit for my career. I was influenced by several inspiring mentors who first encouraged me to enter pediatric gastroenterology and then drew me to study eosinophilic diseases.

In 2010, I was awarded a national Junior Faculty research award from the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. In addition, I achieved the highest patient satisfaction score for the first quarter of 2019 from the Department of Pediatrics at Cincinnati Children’s Hospital Medical Center. My research has been published in numerous manuscripts in journals, including the Journal of Allergy and Clinical Immunology, Journal of Clinical Investigation, Gastroenterology and Genes and Immunity.

BA: University of Pennsylvania, Philadelphia, PA, 1998.

MD: University of Cincinnati, Cincinnati, OH, 2002.

Residency: Pediatrics, Brown University / Hasbro Children’s Hospital, Providence, RI, 2002-2005.

Fellowship: Pediatric Gastroenterology, University of Colorado / Children’s Hospital of Colorado, Denver, CO, 2005-2008.

Research Scholar: University of Colorado / Children’s Hospital of Colorado, Denver, CO, 2008-2009.

Certifications: General Pediatrics, 2005; Pediatric Gastroenterology, 2009.


Eosinophilic gastrointestinal disorders; pediatric feeding problems

Services and Specialties

Gastroenterology GI, Feeding and Swallowing Problems, Eosinophilic Disorders, Aerodigestive and Sleep, Aerodigestive and Esophageal


Eosinophilic gastrointestinal disorders; pediatric feeding problems

Research Areas

Eosinophilic Disorders

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information


Pooled Phase 2 and 3 Efficacy and Safety Data on Budesonide Oral Suspension in Adolescents with Eosinophilic Esophagitis. Mukkada, VA; Gupta, SK; Gold, BD; Dellon, ES; Collins, MH; Katzka, DA; Falk, GW; Williams, J; Zhang, W; Boules, M; et al. Journal of Pediatric Gastroenterology and Nutrition. 2023; 77:760-768.

Treatment of Pediatric Eosinophilic Esophagitis: Traditional and Novel Therapies. Sharlin, CS; Mukkada, VA; Putnam, PE; Bolton, SM. Current Gastroenterology Reports. 2023; 25:289-298.

Esophageal Epithelium and Lamina Propria Are Unevenly Involved in Eosinophilic Esophagitis. Hiremath, G; Sun, L; Collins, MH; Bonis, PA; Arva, NC; Capocelli, KE; Chehade, M; Davis, CM; Falk, GW; Gonsalves, N; et al. Clinical Gastroenterology and Hepatology. 2023; 21:2807-2816.e3.

Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial. Kliewer, KL; Murray-Petzold, C; Collins, MH; Abonia, JP; Bolton, SM; DiTommaso, LA; Martin, LJ; Zhang, X; Mukkada, VA; Putnam, PE; et al. The Lancet Gastroenterology and Hepatology. 2023; 8:803-815.

Local type 2 immunity in eosinophilic gastritis. Ben-Baruch Morgenstern, N; Shoda, T; Rochman, Y; Caldwell, JM; Collins, MH; Mukkada, V; Putnam, PE; Bolton, SM; Felton, JM; Rochman, M; et al. Journal of Allergy and Clinical Immunology. 2023; 152:136-144.

Development of a Practical Guide to Implement and Monitor Diet Therapy for Eosinophilic Esophagitis. Chang, JW; Kliewer, K; Haller, E; Lynett, A; Doerfler, B; Katzka, DA; Peterson, KA; Dellon, ES; Gonsalves, N; Aceves, SS; et al. Clinical Gastroenterology and Hepatology. 2023; 21:1690-1698.

One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial. Kliewer, KL; Gonsalves, N; Dellon, ES; Katzka, DA; Abonia, JP; Aceves, SS; Arva, NC; Besse, JA; Bonis, PA; Caldwell, JM; et al. The Lancet Gastroenterology and Hepatology. 2023; 8:408-421.

Molecular analysis of duodenal eosinophilia. Shoda, T; Rochman, M; Collins, MH; Caldwell, JM; Mack, LE; Osswald, GA; Mukkada, VA; Putnam, PE; Rothenberg, ME. Journal of Allergy and Clinical Immunology. 2023; 151:1027-1039.

Mucosal Microbiota Associated With Eosinophilic Esophagitis and Eosinophilic Gastritis. Furuta, GT; Fillon, SA; Williamson, KM; Robertson, CE; Stevens, MJ; Aceves, SS; Arva, NC; Chehade, M; Collins, MH; Davis, CM; et al. Journal of Pediatric Gastroenterology and Nutrition. 2023; 76:347-354.

Enhancing diversity, equity, inclusion, and accessibility in eosinophilic gastrointestinal disease research: the consortium for eosinophilic gastrointestinal disease researchers' journey. Chehade, M; Furuta, G; Klion, A; Abonia, JP; Aceves, S; Bose, P; Collins, MH; Davis, C; Dellon, ES; Eickel, G; et al. Therapeutic Advances in Rare Disease. 2023; 4:26330040231180895.

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey

Overall Patient Rating